These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 18843795)

  • 1. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
    Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A.
    McKenzie HA; Fung C; Becker TM; Irvine M; Mann GJ; Kefford RF; Rizos H
    Hum Mutat; 2010 Jun; 31(6):692-701. PubMed ID: 20340136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence.
    Brookes S; Gagrica S; Sanij E; Rowe J; Gregory FJ; Hara E; Peters G
    Cell Cycle; 2015; 14(8):1164-73. PubMed ID: 25695870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
    Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
    J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
    Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
    Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms.
    Ruas M; Gregory F; Jones R; Poolman R; Starborg M; Rowe J; Brookes S; Peters G
    Mol Cell Biol; 2007 Jun; 27(12):4273-82. PubMed ID: 17420273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p16(Ink4a) in melanocyte senescence and differentiation.
    Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
    J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function.
    Morris M; Hepburn P; Wynford-Thomas D
    Oncogene; 2002 Jun; 21(27):4277-88. PubMed ID: 12082615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6.
    Jones R; Ruas M; Gregory F; Moulin S; Delia D; Manoukian S; Rowe J; Brookes S; Peters G
    Cancer Res; 2007 Oct; 67(19):9134-41. PubMed ID: 17909018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene-induced senescence does not require the p16(INK4a) or p14ARF melanoma tumor suppressors.
    Haferkamp S; Scurr LL; Becker TM; Frausto M; Kefford RF; Rizos H
    J Invest Dermatol; 2009 Aug; 129(8):1983-91. PubMed ID: 19212341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy.
    Kong Y; Sheng X; Wu X; Yan J; Ma M; Yu J; Si L; Chi Z; Cui C; Dai J; Li Y; Yu H; Xu T; Tang H; Tang B; Mao L; Lian B; Wang X; Yan X; Li S; Guo J
    Clin Cancer Res; 2017 Nov; 23(22):6946-6957. PubMed ID: 28830923
    [No Abstract]   [Full Text] [Related]  

  • 12. CREG1 enhances p16(INK4a) -induced cellular senescence.
    Moolmuang B; Tainsky MA
    Cell Cycle; 2011 Feb; 10(3):518-30. PubMed ID: 21263217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.
    Sandhu C; Peehl DM; Slingerland J
    Cancer Res; 2000 May; 60(10):2616-22. PubMed ID: 10825132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
    Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
    Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
    Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive oxygen species promotes cellular senescence in normal human epidermal keratinocytes through epigenetic regulation of p16(INK4a.).
    Sasaki M; Kajiya H; Ozeki S; Okabe K; Ikebe T
    Biochem Biophys Res Commun; 2014 Sep; 452(3):622-8. PubMed ID: 25181340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
    Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
    Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E47 Governs the MYC-CDKN1B/p27
    Scully KM; Lahmy R; Signaevskaia L; Sasik R; Medal R; Kim H; French R; James B; Wu Y; Lowy AM; Itkin-Ansari P
    Cell Mol Gastroenterol Hepatol; 2018; 6(2):181-198. PubMed ID: 30003124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional impairment of melanoma-associated p16(INK4a) mutants in melanoma cells despite retention of cyclin-dependent kinase 4 binding.
    Becker TM; Rizos H; Kefford RF; Mann GJ
    Clin Cancer Res; 2001 Oct; 7(10):3282-8. PubMed ID: 11595726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
    Shapiro GI; Edwards CD; Rollins BJ
    Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.